Most cited papers from Biofrontera (Germany)

Biofrontera (Germany)

What are the most cited papers from Biofrontera (Germany)?

The most cited paper from Biofrontera (Germany) is "Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder" (Ricardo Segurado et al., 2003), with 572 citations. Next come "Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells" (186) and "Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo" (181).

Published TypeFieldAccessCitations

Showing 50 of 66 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder Ricardo Segurado et al. · The American Journal of Human Genetics ReviewOpen access	Jul 2003	572
2	Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells Sebastian Poliak, Sean Matlis, Christoph Ullmer et al. · The Journal of Cell Biology Open access	28 Oct 2002	186
3	Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo Thomas Dirschka et al. · British Journal of Dermatology	12 Sep 2011	181
4	Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Christine C. Stichel, Xin‐Ran Zhu, Verian Bader et al. · Human Molecular Genetics Open access	5 Apr 2007	179
5	Synaptic multiprotein complexes associated with 5‐HT2C receptors: a proteomic approach Carine Bécamel, Gérard Alonso, Nathalie Galéotti et al. · The EMBO Journal Open access	15 May 2002	172
6	Interaction of Serotonin 5-Hydroxytryptamine Type 2C Receptors with PDZ10 of the Multi-PDZ Domain Protein MUPP1 Carine Bécamel, Andrea Figge, Sebastian Poliak et al. · Journal of Biological Chemistry Open access	Apr 2001	169
7	The mouse MPTP model: gene expression changes in dopaminergic neurons Kati Kühn, Jennifer Wellen, Nina M. Link et al. · European Journal of Neuroscience	2003	166
8	The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease D. Scheller, Christoph Ullmer, Reinhard Berkels et al. · Naunyn-Schmiedeberg s Archives of Pharmacology	13 Aug 2008	153
9	Inflammatory processes in the aging mouse brain: Participation of dendritic cells and T-cells Christine C. Stichel, Hermann Luebbert · Neurobiology of Aging	8 Sep 2006	151
10	Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study Rolf‐Markus Szeimies, Peter Radny, Michael Sebastian et al. · British Journal of Dermatology	28 May 2010	127
11	Non‐motor behavioural impairments in parkin‐deficient mice Xin‐Ran Zhu, Lyutha Maskri, Christina Josefa Herold et al. · European Journal of Neuroscience	22 Sep 2007	114
12	Stretched Poly(vinyl acetate) Gels as NMR Alignment Media for the Measurement of Residual Dipolar Couplings in Polar Organic Solvents Jens Freudenberger, Sebastian Knör, Kyryl M. Kobzar et al. · Angewandte Chemie International Edition	29 Dec 2004	107
13	Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis Thomas Dirschka et al. · British Journal of Dermatology Open access	18 Dec 2012	104
14	Parkin expression in the adult mouse brain Christine C. Stichel, Martin A. Augustin, Kati Kühn et al. · European Journal of Neuroscience	Dec 2000	96
15	A randomized, double‐blind, phase III , multicentre study to evaluate the safety and efficacy of BF ‐200 ALA (Ameluz ® ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF ‐Rhodo LED ® lamp Uwe Reinhold, Thomas Dirschka, Rolf Ostendorf et al. · British Journal of Dermatology Open access	27 Feb 2016	94
16	Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria Saskia Schmidt, Bettina Linnartz‐Gerlach, S. Mendritzki et al. · Human Molecular Genetics Open access	6 Jan 2011	87
17	Sgk1, a cell survival response in neurodegenerative diseases Bodo Schoenebeck, Verian Bader, Xin‐Ran Zhu et al. · Molecular and Cellular Neuroscience	26 Aug 2005	84
18	Parkin Directly Modulates 26S Proteasome Activity Ji Won Um, Eunju Im, Hyun Jung Lee et al. · Journal of Neuroscience Open access	Sep 2010	82
19	Upregulation of cathepsin S in the aging and pathological nervous system of mice Wiebke Wendt, Hermann Lübbert, Christine C. Stichel · Brain Research	30 Jul 2008	75
20	Upregulation of cathepsin S in psoriatic keratinocytes Alexander Schönefuß, Wiebke Wendt, Benjamin Schattling et al. · Experimental Dermatology Open access	22 Oct 2009	73
21	A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy Colin A. Morton et al. · British Journal of Dermatology Open access	12 Feb 2018	72
22	Differential expression of cathepsin X in aging and pathological central nervous system of mice Wiebke Wendt, Xin‐Ran Zhu, Hermann Lübbert et al. · Experimental Neurology	14 Jan 2007	67
23	Expression of DJ-1 in the adult mouse CNS Verian Bader, Xin‐Ran Zhu, Hermann Lübbert et al. · Brain Research	11 Mar 2005	67
24	Molecular interaction between parkin and PINK1 in mammalian neuronal cells Ji Won Um, Christine C. Stichel-Gunkel, Hermann Lübbert et al. · Molecular and Cellular Neuroscience	9 Jan 2009	61
25	A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF ‐200 ALA gel and MAL cream for the treatment of actinic keratosis Thomas Dirschka, S. Ekanayake‐Bohlig, Rolf Dominicus et al. · Journal of the European Academy of Dermatology and Venereology Open access	19 Jul 2018	60
26	Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice Lyutha Maskri, Xin‐Ran Zhu, Sabrina Fritzen et al. · Neurodegenerative Diseases	2004	46
27	sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease Christine C. Stichel, Bodo Schoenebeck, Montserrat Foguet et al. · European Journal of Neuroscience	2005	44
28	Streamlining Culture Conditions for the Neuroblastoma Cell Line SH-SY5Y: A Prerequisite for Functional Studies Sebastian Feles, Christian Overath, Sina Reichardt et al. · Methods and Protocols Open access	12 Jul 2022	41
29	Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain Anna Leichsenring, Michael Andriske, Ingo Bäcker et al. · Naunyn-Schmiedeberg s Archives of Pharmacology	17 Jan 2009	39
30	Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression Wolfgang G. Philipp‐Dormston, Karolina Müller, Ben Novak et al. · Journal of the European Academy of Dermatology and Venereology Open access	18 Nov 2017	37
31	Expression of MUPP1 protein in mouse brain Barbara Sitek, Gereon Poschmann, Katja Schmidtke et al. · Brain Research	Apr 2003	35
32	PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1 Haihong Guo, Fabian Treude, Oliver Holger Krämer et al. · Scientific Reports Open access	19 Jun 2019	31
33	Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin Roxane Schulten, Ben Novak, Beate Schmitz et al. · Naunyn-Schmiedeberg s Archives of Pharmacology	17 Jul 2012	30
34	Intra‐ versus extracellular effects of microglia‐derived cysteine proteases in a conditioned medium transfer model Wiebke Wendt, Roxane Schulten, Christine C. Stichel et al. · Journal of Neurochemistry Open access	17 Jul 2009	30
35	Cryptic fragment α4 LG4‐5 derived from laminin α4 chain inhibits de novo adipogenesis by modulating the effect of fibroblast growth factor‐2 Hironobu Yamashita, Chie Goto, Rie Tajima et al. · Development Growth & Differentiation	7 Dec 2007	29
36	Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease D. Scheller, Christine C. Stichel-Gunkel, Hermann Lübbert et al. · Neuroscience Letters	3 Jan 2008	27
37	Nocardia tenerifensis sp. nov. Peter Kämpfer, Sandra Buczolits, Udo Jäckel et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY	Mar 2004	25
38	Parkin expression in the developing mouse Kati Kühn, Xin‐Ran Zhu, Hermann Lübbert et al. · Developmental Brain Research	23 Mar 2004	25
39	Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis Anna Leichsenring, Bettina Linnartz‐Gerlach, Xin‐Ran Zhu et al. · Brain Research	Jun 2006	24
40	BF-1 – A novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs Beate Schmitz, Christoph Ullmer, Daniel Segelcke et al. · European Journal of Pharmacology	7 Feb 2015	22
41	Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinoma Lutz Schmitz, Beni Moreinas Grinblat, Ben Novak et al. · Journal of the European Academy of Dermatology and Venereology	12 Apr 2019	21
42	Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain model Anna Leichsenring, Ingo Bäcker, Wiebke Wendt et al. · BMC Neuroscience Open access	12 Aug 2008	17
43	The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells Ben Novak, Ludwig Heesen, Nicole Schary et al. · Photodiagnosis and Photodynamic Therapy Open access	7 Feb 2018	15
44	Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence Nathaniel Lampley, Rachel Rigo, Todd E. Schlesinger et al. · Dermatologic Surgery	13 Jan 2023	13
45	Fredericamycin B and C from Streptomyces griseus: Structure Elucidation after 23 Years Bernd Sontag, Johannes Müller, Friedrich G. Hansske · The Journal of Antibiotics Open access	2004	12
46	DEPD®, A HIGH RESOLUTION GENE EXPRESSION PROFILING TECHNIQUE CAPABLE OF IDENTIFYING NEW DRUG TARGETS IN THE CENTRAL NERVOUS SYSTEM Alfred Maelicke, Hermann Lübbert · Journal of Receptors and Signal Transduction	2002	10
47	Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines Nicole Schary, Ben Novak, Laura Kämper et al. · Photodiagnosis and Photodynamic Therapy Open access	8 Jul 2022	9
48	Potency of different red light sources in photodynamic induction of cell death in a squamous cell carcinoma cell line Ben Novak, Monika Peteja, Thomas Brueck et al. · Photodiagnosis and Photodynamic Therapy Open access	11 Mar 2016	9
49	Unusual Teratology for a Tenebrionid: Antennal Schistomelia inProbaticus granulatus(Allard, 1876) (Coleoptera: Tenebrionidae) Julio Abad Ferrer, Jorge Fernández-López, Ángel Fernández González et al. · The Coleopterists Bulletin Open access	Mar 2014	9
50	Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians Adelaide Ann Hebert, John Browning, Pearl C. Kwong et al. · Journal of Drugs in Dermatology Open access	Jul 2023	8

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.